Attached files
| file | filename |
|---|---|
| EX-99.4 - CONSENT OF THOMAS FOLINSBEE, DIRECTOR NOMINEE - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex99iv_bisoncap.htm |
| EX-23.1 - CONSENT OF MARCUM LLP - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex23i_bisoncap.htm |
| EX-10.9 - FORM OF INDEMNITY AGREEMENT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex10ix_bisoncap.htm |
| EX-8.1 - FORM OF TAX OPINION OF HUNTER TAUBMAN FISCHER & LI LLC - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex8i_bisoncap.htm |
| EX-5.2 - FORM OF OPINION OF HUNTER TAUBMAN FISCHER & LI LLC - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex5ii_bisoncap.htm |
| EX-5.1 - FORM OF OPINION OF OGIER - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex5i_bisoncap.htm |
| EX-3.2 - FORM OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1ex3ii_bisoncap.htm |
| S-1/A - AMENDED REGISTRATION STATEMENT - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | fs12017a1_bisoncap.htm |
Exhibit 99.5
CONSENT OF DIRECTOR NOMINEE
As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a Director Nominee in the Registration Statement on Form S-1 of Bison Capital Acquisition Corp. (the “Company”), file number 333-218404, originally submitted on April 18, 2017, and any and all amendments thereto, registering securities for issuance in the Company’s initial public offering.
| Dated: June 15, 2017 | /s/ Ning Wang | |
| Ning Wang |